Slides on HIV Prevention and Screening and COVID-19 Vaccination Among PWH

Consider expert insights on lessons learned during the COVID-19 pandemic about maintaining HIV screening and prevention services when overall healthcare access is severely limited. Slideset also includes the latest information on COVID-19 risk and prevention approaches for people with HIV.
Karine Lacombe, MD, PhD
Renslow Sherer, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.82 MB
Released: October 13, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This program is supported by an educational grant from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Dr Milosz Parczewski discusses HIV Glasgow 2022 reports on the impact of the war in Ukraine on HIV care in Eastern Europe, from Clinical Care Options (CCO)

Milosz Parczewski, MD, PhD Released: November 22, 2022

Expert discussion of data reported at IDWeek 2022 on serologic response to the HepB-CpG vaccine in people with HIV, from Clinical Care Options (CCO)

Joseph J. Eron, Jr., MD Released: November 22, 2022

Expert selections of cutting-edge HIV data, including the latest on long-acting therapies and pre-exposure prophylaxis.

Jeffrey Kwong, DNP, MPH, FAANP, FAAN Released: November 22, 2022

Clinical Care Options (CCO) presents expert faculty discussing new data from AIDS 2022, from nursing perspectives

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
person default Allison Webel, PhD, RN Mitchell J. Wharton, PhD, RN, FNP-BC, CNS, ACRN
Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: November 22, 2022 Expired: November 21, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings